Main protease of SARS-CoV-2 serves as a bifunctional molecule in restricting type I interferon antiviral signaling

被引：0
|
作者：
Yaoxing Wu
Ling Ma
Zhen Zhuang
Sihui Cai
Zhiyao Zhao
Lingli Zhou
Jing Zhang
Pei-Hui Wang
Jincun Zhao
Jun Cui
机构：
[1] Sun Yat-sen University,MOE Key Laboratory of Gene Function and Regulation, State Key Laboratory of Biocontrol, School of Life Sciences
[2] The First Affiliated Hospital of Guangzhou Medical University,State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Disease
[3] Shandong University,Advanced Medical Research Institute, Cheeloo College of Medicine
来源：
Signal Transduction and Targeted Therapy | / 5卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] The SARS-CoV-2 main protease as drug target
    Ullrich, Sven
    Nitsche, Christoph
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2020, 30 (17)
  • [22] Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling
    Israelow, Benjamin
    Song, Eric
    Mao, Tianyang
    Lu, Peiwen
    Meir, Amit
    Liu, Feimei
    Alfajaro, Mia Madel
    Wei, Jin
    Dong, Huiping
    Homer, Robert J.
    Ring, Aaron
    Wilen, Craig B.
    Iwasaki, Akiko
    JOURNAL OF EXPERIMENTAL MEDICINE, 2020, 217 (12):
  • [23] Developing inhibitors of the SARS-CoV-2 main protease
    Seitz, Christian
    Markota, Vedran
    Sztain-Pedone, Terra
    Esler, Morgan
    Moghadasi, Arad
    Kennelly, Samantha
    Demir, Ozlem
    Aihara, Hideki
    Harki, Daniel A.
    Harris, Reuben
    McCammon, J. Andrew
    Amaro, Rommie E.
    BIOPHYSICAL JOURNAL, 2022, 121 (03) : 192A - 192A
  • [24] Potential SARS-CoV-2 main protease inhibitors
    Banerjee, Riddhidev
    Perera, Lalith
    Tillekeratne, L. M. Viranga
    DRUG DISCOVERY TODAY, 2021, 26 (03) : 804 - 816
  • [25] On the origins of SARS-CoV-2 main protease inhibitors
    Janin, Yves L.
    RSC MEDICINAL CHEMISTRY, 2024, 15 (01): : 81 - 118
  • [26] Peptidomimetic inhibitors of SARS-COV-2 main protease
    Angeles Bonache, Ma.
    Algar, Sergio
    Medina, Jessy
    Diaz-Agustin, Aitor
    Bueno, Paula
    Castro, Victoria
    Fabrega, Montserrat
    Coll, Miquel
    Garaigorta, Urtzi
    Gastaminza, Pablo
    Martin Martinez, Mercedes
    Gonzalez-Muniz, Rosario
    JOURNAL OF PEPTIDE SCIENCE, 2024, 30
  • [27] Allosteric Hotspots in the Main Protease of SARS-CoV-2
    Stromich, Leonie
    Wu, Nan
    Barahona, Mauricio
    Yaliraki, Sophia N.
    JOURNAL OF MOLECULAR BIOLOGY, 2022, 434 (17)
  • [28] Perspectives on SARS-CoV-2 Main Protease Inhibitors
    Gao, Kaifu
    Wang, Rui
    Chen, Jiahui
    Tepe, Jetze J.
    Huang, Faqing
    Wei, Guo-Wei
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (23) : 16922 - 16955
  • [29] Type I Interferon Susceptibility Distinguishes SARS-CoV-2 from SARS-CoV
    Lokugamage, Kumari G.
    Hage, Adam
    de Vries, Maren
    Valero-Jimenez, Ana M.
    Schindewolf, Craig
    Dittmann, Meike
    Rajsbaum, Ricardo
    Menachery, Vineet D.
    JOURNAL OF VIROLOGY, 2020, 94 (23)
  • [30] Antiviral peptides against the main protease of SARS-CoV-2: A molecular docking and dynamics study
    Mahmud, Shafi
    Biswas, Suvro
    Paul, Gobindo Kumar
    Mita, Mohasana Akter
    Afrose, Shamima
    Hasan, Md Robiul
    Shimu, Mst Sharmin Sultana
    Uddin, Mohammad Abu Raihan
    Uddin, Md Salah
    Zaman, Shahriar
    Kibria, K. M. Kaderi
    Khan, Md Arif
    Bin Emran, Talha
    Abu Saleh, Md
    ARABIAN JOURNAL OF CHEMISTRY, 2021, 14 (09)
12345